Activiomics | GenomeWeb

Activiomics

NEW YORK (GenomeWeb News) – Retroscreen Virology Group today announced it has acquired proteomics firm Activiomics for up to £4.0 million ($6.7 million).
In connection with the deal, Retroscreen is issuing up to £4.0 million of new ordinary shares of £.05 each of its stock, it said.

Having validated the performance of its mass spec-based TIQUAS system for the identification of protein biomarkers in clinical samples, proteomics firm Activiomics is now aiming to step up its biomarker development efforts.

NEW YORK (GenomeWeb News) – Life Technologies said this week that it has opened up a 'Customer Experience Centre' in Russia in collaboration with one of its distributors, Khimexpert.

NEW YORK (GenomeWeb News) – Activiomics announced recently a research deal with Kyowa Hakko Kirin for use of Activiomics' mass spectrometry-based technology to "elucidate signaling mechanism of lead compounds in relevant cell-based systems."

NEW YORK (GenomeWeb News) – BioFocus will offer its customers Activiomics' proteomics services for identifying novel biomarkers for diagnostics and targets for new drugs, the companies said today.

A team from the Barts Cancer Institute at the Queen Mary University of London has completed a quantitative phosphoproteomic analysis of acute myeloid leukemia cells that suggests that resistance to kinase inhibitor therapies in cancer may be keyed by multiple pathways outside tho

Activiomics announced this week it has appointed Trevor Nicholls to its board as a non-executive chairman.

The investment will be used to further grow partnerships with pharma and biotech companies as well as to pursue identification of prognostic and diagnostic protein biomarkers for cancer, the company said.

The UK firm will use the investment to further build partnerships with pharmaceutical and biotech firms and identify novel biomarkers.

The agreement calls for the company to apply its mass spec-based phosphoproteomics platform to the study of cell signaling pathways targeted by UCB's therapeutic antibodies and to identify potential protein biomarkers linked to the drugs.

Pages

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.